Vertex Inc. logo

Vertex Inc. (0A3L)

Market Closed
13 Oct, 03:30 PM
LSE LSE
$
12. 87
-0.13
-1%
$
- Market Cap
- P/E Ratio
- Div Yield
248 Volume
0.38 Eps
$ 13
Previous Close
Add Transaction
Day Range
12.65 13.28
Year Range
10.25 26.45
Want to track 0A3L and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

0A3L closed Tuesday lower at $12.87, a decrease of -1% from Monday's close, completing a monthly increase of 7.9698% or $0.95. Over the past 12 months, 0A3L stock lost -36.1924%.
0A3L is not paying dividends to its shareholders.
The last earnings report, released on May 06, 2026, missed the consensus estimates by -0.16%. On average, the company has fell short of earnings expectations by -0.16%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on NASDAQ (NMS) (USD).

0A3L Chart

Forget Cystic Fibrosis: Vertex's Next Growth Engine Could Be Hormone Disorders

Forget Cystic Fibrosis: Vertex's Next Growth Engine Could Be Hormone Disorders

Thanks to its most recent acquisition, Vertex now has some promising products in the field of hormone disorders. These could eventually become meaningful growth drivers for the company.

Fool | 1 day ago
Vertex Built The NaV1.8 Market, Latigo May Be The One To Profit From It

Vertex Built The NaV1.8 Market, Latigo May Be The One To Profit From It

Latigo Biotherapeutics is undervalued below IPO, with onzotrigine showing superior efficacy to Vertex's Journavx in acute pain. LTGO leverages Vertex's market groundwork, has pivotal-eligible Phase 2 data, and is funded into 2029, reducing near-term financing risk. Onzotrigine's Phase 3 bunionectomy trial is the key binary event; positive results could drive significant upside versus current market expectations.

Seekingalpha | 5 days ago
Vertex Pharmaceuticals Eyes Renal Growth With Key PDUFA, Pipeline Catalysts Ahead

Vertex Pharmaceuticals Eyes Renal Growth With Key PDUFA, Pipeline Catalysts Ahead

Vertex Pharmaceuticals NASDAQ: VRTX is continuing to broaden its business beyond cystic fibrosis, with its renal medicine portfolio, rare endocrine assets and cell therapies among the company's priorities, CEO and President Reshma Kewalramani said at Morgan Stanley's 24th Annual Healthcare Conference.

Marketbeat | 1 month ago

Vertex Inc. (0A3L) FAQ

What is the stock price today?

The current price is $12.87.

On which exchange is it traded?

Vertex Inc. is listed on LSE.

What is its stock symbol?

The ticker symbol is 0A3L.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Vertex Inc. ever had a stock split?

No, there has never been a stock split.

Vertex Inc. Profile

Software Industry
Information Technology Sector
Christopher David Young CEO
LSE Exchange
92538J106 CUSIP
US Country
2,000 Employees
- Last Dividend
- Last Split
29 Jul 2020 IPO Date

Overview

Vertex, Inc., established in 1978 and based in King of Prussia, Pennsylvania, operates internationally, offering cutting-edge tax technology solutions tailored for the retail trade, wholesale trade, and manufacturing industries. The company specializes in helping enterprises navigate the complex landscape of tax determination, compliance, reporting, and data management through a suite of products and services delivered both as traditional software licenses and modern Software as a Service (SaaS) subscriptions. With a focus on innovation, Vertex, Inc. leverages its extensive experience and industry-specific insights to provide comprehensive tax technology solutions designed to meet the evolving needs of its global clientele.

Products and Services

  • Tax Determination - Vertex provides advanced solutions for accurate tax determination, ensuring compliance with local, state, and international tax regulations.
  • Compliance and Reporting - This service encompasses workflow management tools, role-based security, and event logging to streamline tax compliance and reporting processes.
  • Tax Data Management - Aims to efficiently manage and organize tax-related data, allowing for enhanced accuracy and accessibility.
  • Document Management - Offers solutions for the secure storage, retrieval, and management of tax documents, facilitating easier audit and compliance.
  • Analytics and Insights - Provides analytical tools and insights to help businesses make informed decisions based on their tax data.
  • Pre-built Integration - Includes mapping data fields, business logic, and configurations for seamless integration with existing business systems.
  • Industry-specific Solutions - Tailored solutions designed to meet the unique tax challenges of various industries.
  • Technology Specific Solutions - Includes offerings like chain flow accelerator and SAP-specific tools to enhance tax processing for businesses utilizing specific technologies.
  • Implementation Services - Vertex offers configuration, data migration, implementation support, and training to ensure successful software deployment.
  • Managed Services - This comprehensive service includes tax return preparation, filing, tax payment, and notice management, allowing businesses to outsource their tax management.

Contact Information

Address: 2301 Renaissance Boulevard
Phone: 800 355 3500